Mark Demitrack
Directeur Technique/Scientifique/R&D chez TREVENA, INC.
Fortune : 8 001 $ au 30/06/2024
Profil
Mark A.
Demitrack is currently the Chief Medical Officer & Senior Vice President at Trevena, Inc. He is also a Member of the American College of Neuropsychopharmacology.
Previously, he worked as the Medical Director-New Antidepressant Team at Lilly Research Laboratories.
From 2003 to 2017, he served as the Chief Medical Officer & Vice President at Neuronetics, Inc. He was also the Vice President-Clinical Strategy at Roivant Sciences Ltd.
from 2017 to 2018.
Additionally, he held the position of Assistant Vice President-Global Medical Affairs at Wyeth Pharmaceuticals, Inc. Dr. Demitrack completed his undergraduate degree at The Trustees of Columbia University in The City of New York and obtained his doctorate from Robert Wood Johnson Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TREVENA, INC.
0,20% | 29/04/2024 | 36 700 ( 0,20% ) | 8 001 $ | 30/06/2024 |
Postes actifs de Mark Demitrack
| Sociétés | Poste | Début |
|---|---|---|
| TREVENA, INC. | Directeur Technique/Scientifique/R&D | 21/05/2018 |
American College of Neuropsychopharmacology
 American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | Corporate Officer/Principal | - |
Anciens postes connus de Mark Demitrack
| Sociétés | Poste | Fin |
|---|---|---|
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 01/05/2018 |
| NEURONETICS, INC. | Directeur Technique/Scientifique/R&D | 01/05/2017 |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Corporate Officer/Principal | - |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Corporate Officer/Principal | - |
Formation de Mark Demitrack
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| Robert Wood Johnson Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NEURONETICS, INC. | Health Technology |
| TREVENA, INC. | Health Technology |
| ROIVANT SCIENCES LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Health Technology |
American College of Neuropsychopharmacology
American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | Commercial Services |
